According to FutureWise analysis, the market for Adenovirus Diagnostic Testing is expected to grow at a CAGR of 7.10% over the forecast period of 2024-2032.
Adenoviruses are a family of DNA viruses responsible for inducing febrile illnesses in youngsters. They are associated with upper respiratory tract syndromes such as pharyngitis or coryza but can also cause pneumonia. Less commonly, adenoviruses cause gastrointestinal, genitourinary, ophthalmologic, neurologic, and disseminated disease. Most adenoviral diseases are transient, although fatal infections can occur in immunocompromised hosts and occasionally in healthy youngsters and adults. Since adenoviruses are associated with various clinical syndromes and nonspecific manifestations, diagnosis based on clinical criteria alone is challenging. The diagnosis of adenovirus disease should be confirmed in outbreaks of infection and individual patients with serious disease manifestations. Confirmation of adenovirus infection is essential to decide on antiviral agents, exclude other treatable conditions, establish a prognosis, and initiate infection control measures when appropriate.
Earlier diagnostic approaches to Adenovirus detection relied mainly on serological tests and cell culture. In immunosuppressed patients, however, the use of serological tests is limited due to the impaired immune response, and evaluation of positive cultures is a relatively slow method. The recent introduction of PCR-based assays has opened new ways to rapid, specific, and susceptible AdV detection. However, many of these diagnostic approaches need to effectively cover all AdV types or use lower-stringency conditions to permit the detection of genetically highly diverse adenoviruses.
FutureWise Market Research has published a report that provides an insightful analysis adenovirus diagnostic testing market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.
According to the analysis conducted by FutureWise research analysts, adenovirus diagnostic testing market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.